We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A private company pressing a lawsuit alleging Abbott Laboratories defrauded the federal government by inflating its drug prices more than 1,000 percent got a heavyweight on its side with the U.S. Department of Justice (DOJ) filing of its own complaint.